REG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
05/08/2025 15:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250805:nRSE0658Ua&default-theme=true
RNS Number : 0658U Citadel Group 05 August 2025
Ap27
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
1. KEY INFORMATION
(a) Full name of discloser Citadel Group
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a)
The naming of nominee or vehicle companies is insufficient. For a trust, the
trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this MURAL ONCOLOGY PLC
form relates
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state N/A
this and specify identity of offeror/offeree (Note 1)
(e) Date position held/dealing undertaken 4 August 2025
For an opening position disclosure, state the latest practicable date prior to
the disclosure
(f) In addition to the company in 1(c) above, is the discloser also N/A
making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.
Ap28
Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security Common Stock ISIN IE000LK2BOB4
(Note 3)
$0.01 ordinary shares
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled 197,491 1.13 0 0.00
(2) Cash-settled derivatives 253 0.00 23 0.00
(3) Stock-settled derivatives (including options) and agreements to 16,800 0.09 96,700 0.55
purchase/ sell
Total 214,544 1.23 96,723 0.55
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE
DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security
securities (Note 5)
Common Buy Transaction 151 1.6300 USD
Common Buy Transaction 200 1.6750 USD
Common Buy Transaction 62 1.7200 USD
Common Buy Transaction 100 1.7400 USD
Common Buy Transaction 10,493 1.7830 USD
Common Buy Transaction 1 1.7900 USD
Common Buy Transaction 290 1.7913 USD
Common Buy Transaction 14 1.7950 USD
Common Buy Transaction 101 1.8000 USD
Common Buy Transaction 199 1.8003 USD
Common Buy Transaction 733 1.8050 USD
Common Buy Transaction 25 1.8052 USD
Common Buy Transaction 2,631 1.8055 USD
Common Buy Transaction 10,703 1.8118 USD
Common Buy Transaction 26 1.8200 USD
Common Buy Transaction 76 1.8290 USD
Common Buy Transaction 2 1.8300 USD
Common Buy Transaction 365 1.8342 USD
Common Buy Transaction 13 1.8369 USD
Common Buy Transaction 1 1.8394 USD
Common Buy Transaction 13 1.8431 USD
Common Buy Transaction 476 1.8475 USD
Common Buy Transaction 1,500 1.8493 USD
Common Buy Transaction 3,002 1.8500 USD
Common Buy Transaction 1,500 1.8501 USD
Common Buy Transaction 260 1.8501 USD
Common Buy Transaction 21,749 1.8505 USD
Common Buy Transaction 101 1.8510 USD
Common Buy Transaction 14,698 1.8535 USD
Common Buy Transaction 3,708 1.8596 USD
Common Buy Transaction 219 1.8599 USD
Common Buy Transaction 10,767 1.8600 USD
Common Buy Transaction 1,812 1.8710 USD
Common Buy Transaction 6,233 1.8828 USD
Common Buy Transaction 3,949 1.8929 USD
Common Buy Transaction 15,823 1.8948 USD
Common Buy Transaction 18,769 1.8970 USD
Common Buy Transaction 3,123 1.8991 USD
Common Buy Transaction 2,200 1.9483 USD
Common Buy Transaction 1,051 1.9500 USD
Common Buy Transaction 47,907 1.9724 USD
Common Buy Transaction 54 1.9772 USD
Common Buy Transaction 6,623 2.0135 USD
Common Buy Transaction 1,400 2.0200 USD
Common Buy Transaction 1,609 2.0226 USD
Common Buy Transaction 201 2.0229 USD
Common Buy Transaction 400 2.0350 USD
Common Buy Transaction 3,000 2.0400 USD
Common Buy Transaction 1,450 2.0414 USD
Common Buy Transaction 400 2.0500 USD
Common Buy Transaction 2,269 2.0500 USD
Common Buy Transaction 513 2.0501 USD
Common Buy Transaction 734 2.0548 USD
Common Buy Transaction 2 2.0550 USD
Common Buy Transaction 218 2.0696 USD
Common Buy Transaction 502 2.0989 USD
Common Buy Transaction 6,203 2.1000 USD
Common Buy Transaction 9,996 2.1004 USD
Common Buy Transaction 10 2.1110 USD
Common Buy Transaction 3,198 2.1215 USD
Common Buy Transaction 5,622 2.1400 USD
Common Buy Transaction 14,378 2.1517 USD
Common Buy Transaction 3,510 2.1568 USD
Common Buy Transaction 9 2.1811 USD
Common Buy Transaction 4,297 2.1990 USD
Common Sell Transaction 700 1.6186 USD
Common Sell Transaction 452 1.7900 USD
Common Sell Transaction 256 1.7911 USD
Common Sell Transaction 2,000 1.7990 USD
Common Sell Transaction 995 1.8000 USD
Common Sell Transaction 3,280 1.8034 USD
Common Sell Transaction 49 1.8051 USD
Common Sell Transaction 8 1.8100 USD
Common Sell Transaction 1,376 1.8197 USD
Common Sell Transaction 13 1.8262 USD
Common Sell Transaction 152 1.8290 USD
Common Sell Transaction 685 1.8292 USD
Common Sell Transaction 150 1.8296 USD
Common Sell Transaction 8,551 1.8300 USD
Common Sell Transaction 20 1.8350 USD
Common Sell Transaction 898 1.8380 USD
Common Sell Transaction 16,179 1.8382 USD
Common Sell Transaction 500 1.8399 USD
Common Sell Transaction 3,891 1.8446 USD
Common Sell Transaction 2,020 1.8452 USD
Common Sell Transaction 555 1.8464 USD
Common Sell Transaction 2,531 1.8500 USD
Common Sell Transaction 7,695 1.8511 USD
Common Sell Transaction 198 1.8550 USD
Common Sell Transaction 55 1.8595 USD
Common Sell Transaction 11 1.8600 USD
Common Sell Transaction 162 1.8610 USD
Common Sell Transaction 510 1.8646 USD
Common Sell Transaction 500 1.8660 USD
Common Sell Transaction 91 1.8690 USD
Common Sell Transaction 50 1.8700 USD
Common Sell Transaction 1,461 1.9149 USD
Common Sell Transaction 2,390 1.9211 USD
Common Sell Transaction 660 1.9223 USD
Common Sell Transaction 2,002 1.9289 USD
Common Sell Transaction 470 1.9325 USD
Common Sell Transaction 590 1.9364 USD
Common Sell Transaction 8,270 1.9364 USD
Common Sell Transaction 8,763 1.9470 USD
Common Sell Transaction 1,999 1.9613 USD
Common Sell Transaction 2 1.9655 USD
Common Sell Transaction 1,826 1.9681 USD
Common Sell Transaction 25,098 1.9795 USD
Common Sell Transaction 360 1.9800 USD
Common Sell Transaction 100 1.9850 USD
Common Sell Transaction 300 1.9900 USD
Common Sell Transaction 18,657 1.9926 USD
Common Sell Transaction 1,119 2.0018 USD
Common Sell Transaction 1,400 2.0200 USD
Common Sell Transaction 1,505 2.0300 USD
Common Sell Transaction 500 2.0397 USD
Common Sell Transaction 3,000 2.0400 USD
Common Sell Transaction 1 2.0729 USD
Common Sell Transaction 142 2.0816 USD
Common Sell Transaction 200 2.0850 USD
Common Sell Transaction 653 2.1002 USD
Common Sell Transaction 1,050 2.1219 USD
Common Sell Transaction 600 2.1292 USD
Common Sell Transaction 5,100 2.1427 USD
Common Sell Transaction 100 2.1700 USD
Common Sell Transaction 100 2.1800 USD
Common Sell Transaction 3 2.2400 USD
Common Sell Transaction 700 2.2500 USD
Common Sell Transaction 538 2.2600 USD
Ap29
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price
relevant description e.g. opening/ closing a long/ short position, increasing/ reducing a long/ reference per unit
security e.g. CFD short position securities (Note 5)
(Note 6)
Common CFD Increasing short position/ Reducing long position 97 1.7950 USD
Common CFD Closing short position/Opening long position 97 1.8000 USD
Common CFD Closing short position/Opening long position 253 1.8599 USD
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, purchasing, selling, varying Number Exercise Type Expiry Option
relevant description e.g. call etc. of
price per e.g. date money
security option securities unit American,
paid/
to which European received per unit
option
etc.
relates
(Note 6)
Common Call Option Buy Transaction 300 2.5000 USD American 2025-08-15 0.0500 USD
Common Call Option Buy Transaction 12,000 5.0000 USD American 2027-01-15 0.1000 USD
Common Call Option Buy Transaction 2,400 2.5000 USD American 2025-12-19 0.1000 USD
Common Call Option Buy Transaction 400 2.5000 USD American 2025-12-19 0.1500 USD
Common Call Option Buy Transaction 100 5.0000 USD American 2027-01-15 0.1700 USD
Common Put Option Buy Transaction 800 2.5000 USD American 2025-08-15 0.4500 USD
Common Put Option Buy Transaction 1,400 2.5000 USD American 2025-08-15 0.5000 USD
Common Put Option Buy Transaction 100 2.5000 USD American 2025-12-19 0.6000 USD
Common Put Option Buy Transaction 100 5.0000 USD American 2025-08-15 2.9500 USD
Common Put Option Buy Transaction 100 7.5000 USD American 2025-08-15 5.5000 USD
Common Call Option Sell Transaction 200 5.0000 USD American 2027-01-15 0.1000 USD
Common Call Option Sell Transaction 200 5.0000 USD American 2027-01-15 0.1200 USD
Common Call Option Sell Transaction 1,300 5.0000 USD American 2027-01-15 0.1500 USD
Common Call Option Sell Transaction 100 2.5000 USD American 2027-01-15 0.2900 USD
Common Call Option Sell Transaction 100 2.5000 USD American 2027-01-15 0.3500 USD
(ii) Exercise
Class of Product Exercising/ Number of Exercise
relevant description exercised securities price per
security e.g. call against unit
option (Note 5)
(d) Other dealings (including transactions in respect of
new securities) (Note 3)
Class of Nature of dealing Details Price per unit (if
relevant e.g. subscription, applicable)
security conversion, exercise (Note 5)
Ap30
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
(c) Attachments
Is a Supplemental Form 8 attached? YES
Date of disclosure 5 August 2025
Contact name Paula Santos
Telephone number 020 7645 9700
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.
Ap32
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND
RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2022
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING
OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND
RIGHTS TO SUBSCRIBE FOR NEW SECURITIES
1. KEY INFORMATION
Full name of person making Citadel Group
disclosure:
Name of offeror/offeree in relation MURAL ONCOLOGY PLC
to whose relevant securities the
disclosure relates:
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of Product Written or Number of Exercise Type Expiry
relevant description purchased securities to price e.g. date
security e.g. call
which option per unit American,
option
or derivative European
relates etc.
Common Put Option Purchased -7,200 2.5 USD American 19/09/2025
Common Call Option Purchased 400 2.5 USD American 15/08/2025
Common Call Option Purchased 800 5.0 USD American 19/12/2025
Common Put Option Purchased -53,200 2.5 USD American 15/01/2027
Common Call Option Purchased 14,600 5.0 USD American 19/09/2025
Common Put Option Purchased -200 5.0 USD American 19/09/2025
Common Put Option Purchased -200 7.5 USD American 15/08/2025
Common Put Option Purchased -4,500 2.5 USD American 15/08/2025
Common Call Option Purchased 1,000 5.0 USD American 20/03/2026
Common Put Option Purchased -3,100 2.5 USD American 19/12/2025
Common Put Option Purchased -200 5.0 USD American 15/08/2025
Common Call Option Sold -1,600 5.0 USD American 15/01/2027
Common Call Option Sold -17,200 2.5 USD American 19/09/2025
Common Call Option Sold -1,400 2.5 USD American 19/12/2025
Common Call Option Sold -400 2.5 USD American 20/03/2026
Common Call Option Sold -200 7.5 USD American 19/09/2025
Common Call Option Sold -7,300 2.5 USD American 15/01/2027
3. AGREEMENTS TO PURCHASE OR SELL
Full details should be given so that the nature of the interest or position
can be fully understood:
Ap33
4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING
DIRECTORS' AND OTHER EMPLOYEE OPTIONS)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
It is not necessary to provide details on a Supplemental Form with regard to
cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
References in these notes to "the Rules" are to the Irish Takeover Panel Act,
1997, Takeover Rules, 2022.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ITPPKPBPKBKDAFKRecent news on Mural Oncology
See all newsREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG - BlackRock Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
Announcement